跳至主要内容
临床试验/IRCT2013122811763N15
IRCT2013122811763N15已完成未知

Effects of Symbiotic on inflammatory markers, liver function, lipid profile, sonographic findings and body composition in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Vice chancellor for research, Isfahan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • aged 18-60 years; confirmation of NAFLD with Ultrasonography and increased levels of Ast and Alt; desire to participate in the study. Exclusion criteria: organ transplantation; presence of pregnancy and lactation; suffering from Wilson disease; chronic liver diseases unless NAFLD; Diabetes Mellitus; Cancer; antibiotics therapy; Receiving Oral Contraceptive Pill (OCP); drugs such as corticosteroids, Amiodarone, Tamoxifen, Cyclins, Perhexiline, Methotrexate and Hydralazine; Receiving of vitamin-mineral and omega-3 Supplements during the study

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Isfahan University of Medical Sciences

相似试验

Effect of Symbiotic on Non-Alcoholic Fatty Liver... | 临床试验